e2v technologies announces it has secured a multi-year contract renewal worth over £40m.
e2v will supply products from its RF Power division for incorporation within linear accelerators, a key sub-system for radiotherapy cancer treatment machines, to Elekta Ltd, Crawley, UK. The requirement is for both new equipment and the ongoing service and support of installed systems.
The contract is effective from 1st February 2013 and covers a period of 3 years and 3 months.
e2v’s products generate and deliver the microwave power required from the linear accelerator within the radiotherapy cancer treatment system to produce the X-rays used in both the imaging and radiation treatment of tumours.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. Elekta provides intelligent and resource-efficient technologies that improve, prolong and save patient lives.
Keith Attwood CEO of e2v said “this contract with Elekta reinforces our position as a trusted partner for innovative solutions to this important marketplace”.
PRESS OFFICE CONTACT:
Nichola Kelly, Marketing Communications Executive
Nichola.email@example.com Tel: + 44 (0)1245 453438
NOTES FOR EDITORS
e2v is a leading global provider of specialist technology for high performance systems and equipment; delivering solutions, sub-systems and components for applications within medical & science, aerospace & defence, and commercial & industrial markets.
e2v employs approximately 1650 people, has design and operational facilities across Europe, North America and Asia, and has a global network of sales and technical support offices. For the year ended 31 March 2012, e2v reported sales of GBP235m and is listed on the London Stock Exchange.
For more information visit e2v.com